Anticipated shortage of Merck’s fertility drug ‘Gonal-F’
By Lee, Hye-Kyung | translator Kim, Jung-Ju
24.03.14 05:50:39
가나다라
0
Merck anticipates a supply shortage starting from the 15th and expects to return to normal after April 30th
Manufacturing 300/450/900IU is delayed, but 150IU can be used as a substitute drug
▲Merck has announced that 300/450/900IU Gonal-F Pen are expected to be short in supply.
The shortage of Merck’s 'Gonal-F Pen,' which is the world’s first recombinant follicle stimulating hormone (r-FSH), is expected. Merck has announced that three, 300/450/900IU, of the four volumes of Gonal-F Pen approved by the Ministry of Food and Drug Safety (MFDS) are expected to be short in supply. Currently, the 150IU volume is in stock.
Gonal-F, a medication for treating infertility, was approved in South Korea in 2007, following approvals in Europe in 1995 and the United States in 1997. It is used in 100 countries worldwide.
Due to temporary supply delays stemming from manufacturing plant schedule, domestic supply shortages are expected from the 15th.
Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)